Financhill
Sell
34

CNSP Quote, Financials, Valuation and Earnings

Last price:
$0.11
Seasonality move :
-46.41%
Day range:
$0.10 - $0.11
52-week range:
$0.10 - $70.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.87x
Volume:
2.9M
Avg. volume:
7.1M
1-year change:
-99.82%
Market cap:
$6.3M
Revenue:
--
EPS (TTM):
-$70.72

Earnings Data

Next earnings date for CNSP
Apr 01
2025
Most recent earnings per share
-$0.25
Missed by $0.25
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CNSP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2024 Q4 -- -- -- -- --
11/14/2024 Q3 -- -- -$0.25 -- --
08/14/2024 Q2 -- -- -$6.72 -- --
05/15/2024 Q1 -- -- -$20.50 -- --
12/31/2023 Q4 -- -- -$43.25 -- --
11/15/2023 Q3 -- -- -$54.14 -- --
06/30/2023 Q2 -- -- -$51.86 -- --
03/31/2023 Q1 -- -- -$129.50 -- --
12/31/2022 Q4 -- -- -$177.50 -- --
11/11/2022 Q3 -- -- -$128.00 -- --
08/12/2022 Q2 -- -- -$133.50 -- --
05/13/2022 Q1 -- -- -$122.00 -- --
03/03/2022 Q4 -- -- -$180.00 -- --
11/12/2021 Q3 -- -- -$210.00 -- --
08/13/2021 Q2 -- -- -$225.00 -- --
05/14/2021 Q1 -- -- -$225.00 -- --
03/12/2021 Q4 -- -- -$270.00 -- --
11/12/2020 Q3 -- -- -$180.00 -- --
08/13/2020 Q2 -- -- -$225.00 -- --
05/15/2020 Q1 -- -- -$180.00 -- --
03/12/2020 Q4 -- -- -$255.00 -- --
09/30/2019 Q3 -- -- -$75.00 -- --
06/30/2019 Q2 -- -- -$45.00 -- --
03/31/2019 Q1 -- -- -$23.37 -- --
12/31/2018 Q4 -- -- -$732.84 -- --
09/30/2018 Q3 -- -- -$21.35 -- --
06/30/2018 Q2 -- -- -$24.58 -- --

CNS Pharmaceuticals Earnings Questions

  • How Much did CNS Pharmaceuticals Generate in Revenue Last Quarter?

    CNS Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did CNS Pharmaceuticals Beat Earnings Last Quarter?

    CNS Pharmaceuticals announced earnings per share of -$0.25 which represents a miss of analyst forecast a -- per share.

  • Is CNS Pharmaceuticals Profitable?

    CNS Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for CNS Pharmaceuticals EPS Next Year?

    CNS Pharmaceuticals's earnings are forecast to grow from -$500.00 per share to -- per share next year representing an increase of --.

  • When is CNS Pharmaceuticals's Earnings Date?

    CNS Pharmaceuticals's next earnings date is April 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
52
TSLL alert for Dec 24

Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.

Buy
73
PSIX alert for Dec 24

Power Solutions International [PSIX] is up 27.42% over the past day.

Sell
31
SOXL alert for Dec 24

Direxion Daily Semiconductor Bull 3X Shares [SOXL] is up 11.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock